期刊文献+

药物性肝损伤79例临床分析 被引量:3

Clinical analysis of drug-induced liver injury of 79 cases
原文传递
导出
摘要 目的探讨药物性肝损伤(drug-induced liver injury,DILI)的临床特点,为临床早期诊断和治疗提供依据。方法回顾性分析2005年1月至2009年6月79例DILI住院患者的临床资料。结果79例DILI中男性23例,女性56例(1∶2.43);年龄28~87岁,平均为50.4岁。中药致DILI最常见,其次分别为抗生素、抗结核药、解热镇痛药、抗肿瘤药及保健药。发病潜伏期为8d~半年,服抗生素出现DILI的潜伏期最短,其次为解热镇痛药和抗癌药。而中药、抗结核药、降压药、调脂药及保健药等潜伏期较长。68.4%为肝细胞损伤型,10.1%为胆汁瘀积型,21.5%为混合型。治疗结果70例好转,6例痊愈,2例未愈,1例死亡。结论多种药物长期大量应用均可引起DILI,一旦发现应及时对症治疗并定期复查肝功能。 ObjectiveTo discuss the overall clinical features of drug-induced liver injury (DILI) for early diagnosis and treatment.MethodsA retrospective analysis was conducted on 79 inpatients with DILI from January 2005 to June 2009.ResultsThere were 23 male and 56 female (1∶2.43).Ages ranged from 28 to 87 years old (average 50.4 years).The incidence rates of DILI due to Chinese herbs,antibiotics,antituberculotics,antipyretic-analgesics,antitumor agents and health care medicines were 22.8%,15.2%,11.4%,8.9%,7.6% and 5.1% respectively.The incubation periods of DILI ranged from 8 days to 6 months in the majority (89.9%),and in the order of them,the period of antibiotics was the shortest,antipyretic-analgesics and antitumor agents next,Chinese herbs,antituberculotics,blood pressure-lowing agents,blood lipid-adjusting agents and health care medicines relatively longer.By Zakim classification,68.4% cases were hepatocellular type,10.1% cases were cholestatic type and 21.5% cases were mixed type.As the prognosis,70 cases improved,6 cases were healed,2 cases unchanged or became worse and 1 case dead.ConclusionsMany agents could induce liver injury during long-term usage.Once DILI is discovered,treating in time and rechecking liver function regularly should be performed.
出处 《中国临床研究》 CAS 2010年第3期191-192,共2页 Chinese Journal of Clinical Research
关键词 药物性肝损伤 临床分析 Drug-induced liver injury Clinical analysis
  • 相关文献

参考文献10

  • 1Andrade RJ, Lueena MI, Fernandez MC. Drug-induced liver injury:an analysis of 461 incidences submitted to the Spanish registry over a 10- year period [ J ]. Gastroenterology, 2005,129 ( 2 ) : 512 - 521.
  • 2李新华.110例药物性肝损害临床分析[J].医学信息(下旬刊),2009(4):87-88. 被引量:1
  • 3药物性肝损害病死率位居全球第五[J].肝博士,2006(5):68-69. 被引量:17
  • 4Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries [ J]. J Clin Epidemiol, 1993,46 ( 11 ) : 1323 - 1330.
  • 5Zakim D,Thomas D. Hepatology[M]. 3rd. Philadephia: WB Sanders Company, 1996:962 - 967.
  • 6Wang RS, Nakajima T, Honma T. Different change patterns of the isozymes of cytochrome P450 and glutathione S-tranferases in chemically induced liver damage in rat [ J]. lnd Health, 1999,37 ( 4 ) : 440 - 448.
  • 7厉有名.药物性肝损害的临床类型及诊断策略[J].中华肝脏病杂志,2004,12(7):445-446. 被引量:252
  • 8Kaplowitz N. Drug-induced liver disorders:implications for drug development and regulation[ J]. Drug Saf,2001,24(7) :483 -490.
  • 9Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features ,and outcomes from a prospective study of drug-induced liver injury in the United States[J]. Gastroenterology ,2008,135 (6) : 1924.
  • 10朱素燕,胡毅坚,陈江飞.30例住院患者药物性肝损伤的类型及Danan标准再诊断[J].中国药物与临床,2009,9(6):518-519. 被引量:2

二级参考文献3

共引文献266

同被引文献52

引证文献3

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部